Sustained good momentum, but with some caution
-"After another quarterly performance beat in Q3, Novo remains on track to sustain its exceptional operating momentum. Besides our medium-term estimates resetting marginally higher, the DCF and NAV ..."
You may also be interested by these reports :
Considering the strong operational performance and a meaningful progress for the late-stage pipeline in recent years, we have revised upwards our NAV ...
FY23 CORE EBITDA ahead of consensus by 1%, CORE net profit miss by 4%
Bayer has announced a dividend cut to the legally-required minimum of 4% of AG capital, which translates to a dividend proposal of 11 euro cents ...
Net loss of CHF 207mn confirmed